S. E. Sallan
- Hematology top 5%
-
- Acute Lymphoblastic Leukemia research 9
- Genetics top 5%
- Virus-based gene therapy research 2
- Blood disorders and treatments 2
-
- Childhood Cancer Survivors' Quality of Life 2
-
- Immunodeficiency and Autoimmune Disorders 2
-
- Glycosylation and Glycoproteins Research 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
-
- Lymphoma Diagnosis and Treatment 2
- Co-authors
- RD GelberBarbara L. AsselinHarvey J. CohenJohn C. WhitinJerome RitzBruce L. SlaughenhouptKenneth C. AndersonF Coral
- Journals
- Journal of Clinical Oncology (7 papers)Journal of Clinical Investigation (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesItalyGermany
In The Last Decade
S. E. Sallan
16 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 67
- Hematology 290
- Public Health, Environmental and Occupational Health 585
- Genetics 206
- Pediatrics, Perinatology and Child Health 358
- Immunology 216
Countries citing papers authored by S. E. Sallan
This map shows the geographic impact of S. E. Sallan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Sallan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Sallan more than expected).
Fields of papers citing papers by S. E. Sallan
This network shows the impact of papers produced by S. E. Sallan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Sallan. The network helps show where S. E. Sallan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. E. Sallan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 2 | |
| 2 | 2010 | 1 | |
| 3 | 2010 | 1 | |
| 4 | 2001 | 30 | |
| 5 | Long-term follow-up and infectious complications of therapy for acute lymphoblastic leukemia in children | 2000 | 5 |
| 6 | 1998 | 81 | |
| 7 | 1996 | 3 | |
| 8 | 1993 | 250 | |
| 9 | 1992 | 113 | |
| 10 | 1992 | 25 | |
| 11 | 1991 | 37 | |
| 12 | 1989 | 35 | |
| 13 | Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. | 1985 | 109 |
| 14 | 1984 | 266 | |
| 15 | 1982 | 86 | |
| 16 | 1981 | 13 |
About S. E. Sallan
S. E. Sallan is a scholar working on Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Immunology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (9 papers), Glycosylation and Glycoproteins Research (2 papers), Virus-based gene therapy research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Blood disorders and treatments (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (290 citations), Public Health, Environmental and Occupational Health (585 citations) and Genetics (206 citations). S. E. Sallan has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include RD Gelber, Barbara L. Asselin, Harvey J. Cohen, John C. Whitin, Jerome Ritz, Bruce L. Slaughenhoupt, Kenneth C. Anderson, F Coral, R. John Mayer and Jane P. Jensen. Their work appears in journals such as Journal of Clinical Oncology, Journal of Clinical Investigation, International Journal of Radiation Oncology*Biology*Physics, Leukemia and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.